Healthcare, Pharma & Life Sciences

Memorial Hermann Cuts Patient Follow-Up Messages 32% With Epic AI

Image
Memorial Hermann Cuts Patient Follow-Up Messages 32% With Epic AI

Houston – September 12, 2026 -- Memorial Hermann Health System has cut patient follow-up messages about test results by 32% after deploying Art, an AI-powered documentation assistant built into its Epic electronic health record system.

Clinicians save nine seconds per result comment using AI-drafted notes

Art generates an initial draft patient note in plain language as clinicians review lab and imaging results in Epic's In Basket, replacing complex medical terminology with patient-friendly explanations. Clinicians then review, edit and personalize each draft before sending it to patients. Care teams at Memorial Hermann have used the tool to write more than 55,000 patient messages since adoption began, with clinicians saving an average of nine seconds per result comment when starting from Art's draft.

Natural Field Expands NF TriSolve® Platform Into Sleep Wellness

Image
Natural Field Expands NF TriSolve® Platform Into Sleep Wellness

Shanghai – September 12, 2026 -- Natural Field has extended its NF TriSolve® nutraceutical solutions platform into the sleep wellness category with the launch of the NF TriSolve® SleepRestore complex.

New complex combines multiple functional ingredients for sleep-focused formulations

The SleepRestore complex integrates several functional components within a single formulation concept designed for nutraceutical applications targeting sleep. The launch marks Natural Field's entry into the expanding sleep wellness market, built on a solutions-oriented development approach rather than single-ingredient focus.

EvidenceCare Taps John Voigt Jr. as Chief Revenue Officer

Image
EvidenceCare Taps John Voigt Jr. as Chief Revenue Officer

Nashville, Tenn. – September 12, 2026 -- EvidenceCare has named John Voigt Jr. as its first unified Chief Revenue Officer, consolidating sales and marketing under one executive as the clinical performance improvement platform enters its next growth phase.

Voigt brings a track record of scaling healthcare technology revenue functions

Voigt previously served as executive vice president of growth and strategy at ActiumHealth (Syllable AI), where he led commercial strategy for the company's AI-driven patient access platform. Before that, he directed health system growth strategy at Wellvana Health, building partnerships that generated more than $200 million in annual risk revenue. Earlier in his career, he helped grow Cedar's annual recurring revenue from $2 million to over $85 million.

Fidelis Care Opens $140,000 Maternal Health Grant Program in NY

Image
Fidelis Care Opens $140,000 Maternal Health Grant Program in NY

Long Island City, N.Y. – September 12, 2026 -- Fidelis Care, a Centene Corporation health plan serving more than two million members across New York State, has opened applications for up to $140,000 in Here for Your Health maternal health grants targeting postpartum care gaps in underserved communities.

Grant deadline set for September 21 as postpartum visit adherence lags nationally

Applications are available at fideliscare.org/maternal-grant, with a submission deadline of 5 p.m. on September 12, 2026. The grants will fund healthcare providers and community-based organizations developing solutions to improve postpartum visit attendance and expand maternal depression screening.

Curaleaf Rebuts Aurora Cannabis Claims, Defends Takeover Premium

Stamford, Conn. – – September 12, 2026 -- Curaleaf Holdings, Inc. released a fact sheet countering what it called inaccurate statements by Aurora Cannabis Inc. regarding Curaleaf's proposal to acquire the company, arguing its offer represents one of the highest premiums in a decade of Canadian M&A.

Curaleaf says its bid carries a 110% premium once Aurora's cash is excluded

Curaleaf's headline offer reflects a 45% premium, which the company says ranks among the higher Canadian M&A premiums of the past ten years. Stripping out cash on Aurora's balance sheet, Curaleaf calculates the effective premium at 110%. Curaleaf noted Aurora has continued issuing shares through an At-the-Market program at prices below the value implied by the offer, even after the bid was made public.

Livmor Wins CMS Blue Button Access, Adds Disenrollment Alerts Before AEP

Portland, Oregon – September 12, 2026 -- Livmor Inc. has been approved for Centers for Medicare & Medicaid Services (CMS) Blue Button API access and named to the CMS Blue Button V3 Advisory Council, giving its LivmorIQ platform direct visibility into real Medicare beneficiary claims and prescription data.

The integration rolls out to LivmorIQ customers later this month alongside a new Disenrollment Notification feature, timed ahead of the October 15 start of the Annual Enrollment Period (AEP).

SciBase Gets $0.6M Order From Castle Biosciences on AD Study

Stockholm – September 12, 2026 -- SciBase Holding AB (STO: SCIB) has received an additional order worth roughly $0.6 million, or approximately SEK 5 million, from Castle Biosciences (NASDAQ: CSTL) to accelerate an ongoing clinical study and prepare a second trial under their dermatology collaboration.

Order covers Nevisense Go devices and electrodes for atopic dermatitis research

The order includes both SciBase's portable Nevisense Go pen device and associated electrodes. Deliveries are scheduled to begin in the fourth quarter of 2026.

Collaboration targets relapse prediction in atopic dermatitis patients

SciBase and Castle Biosciences entered a collaboration and license agreement in 2025. The first joint study under that agreement aims to predict relapses in atopic dermatitis and is currently underway, with the new order funding both faster progression of that trial and groundwork for a follow-up study.

German Medical Association Backs Emergency Care Reform, Demands Changes

Berlin – September 12, 2026 -- Germany's Federal Medical Association (Bundesärztekammer) has confirmed support for a cross-sector reform of acute and emergency care, while pushing for amendments before the bill clears parliament.

Reinhardt calls for unified triage system across Germany

Association president Dr. Klaus Reinhardt told the Bundestag Health Committee ahead of a hearing on the draft law that the reform must introduce "genuine care management" needed across other healthcare sectors too. He said a nationwide, standardized initial assessment system is required to ensure patients are directed reliably through the system, with responsibility resting with physician self-governance bodies.

Micah Parsons Takes Equity Stake, Board Seat at RejuvStem

Dallas – September 12, 2026 -- NFL All-Pro Micah Parsons has taken an equity stake and board seat at RejuvStem, a Cancún, Mexico-based regenerative wellness company, as the firm looks to widen its footprint beyond athletic recovery into the broader preventive health market.

Parsons moves from endorsement to equity investor and board member

The deal, negotiated by Athletes First, the sports representation and marketing agency that handles Parsons' on- and off-field business, gives him formal roles as investor, board member and brand ambassador rather than a standard sponsorship arrangement. He will advise RejuvStem on brand growth and strategic initiatives, working to position the company's regenerative therapies and personalized wellness programs to a wider consumer base that includes non-athletes seeking preventive care.

Flyttr to Build First US Large-Scale Biosecurity Platform in San Antonio

Image
Flyttr to Build First US Large-Scale Biosecurity Platform in San Antonio

San Antonio – September 12, 2026 -- Flyttr announced plans to build the nation's first large-scale biosecurity research, development and countermeasures platform in San Antonio, Texas, targeting pest threats including disease-spreading mosquitoes and livestock parasites.

Flyttr's first facility will exceed 130,000 square feet and add over 50 jobs

The initial San Antonio facility is anticipated to rapidly add more than 50 R&D, engineering, operations, and support jobs, growing to over 100 as the platform scales. It adds to laboratory facilities Flyttr already operates at the Texas Biomedical Research Institute, a strategic partner since June 2026.